When a macrophage encounters a bacterial threat, it must quickly signal to natural killer cells for backup—and a protein called CALHM6 is the critical messenger that makes this handoff happen. This project tackles a fundamental gap in immunology: how macrophages, the immune system's first responders, physically communicate with natural killer cells to coordinate an attack. The researchers discovered that CALHM6, a protein that forms ion channels in neurons, is repurposed in immune cells. In resting macrophages, it stays hidden inside the cell. But upon activation, it rushes to the immune synapse—the point of contact between cells—where it may release small molecules like ATP to activate natural killer cells. The team will map this trafficking process, identify the proteins that control it, and test whether CALHM6 actually forms a channel at the synapse. This is fundamental science. If successful, it will reveal a previously unknown mechanism of cell-to-cell communication in the immune system. Understanding how macrophages instruct natural killer cells could eventually inform new strategies for boosting early immune responses against infections or tumours. Past discoveries of similar synaptic signalling in neurons, for instance, led to drugs that modulate neurotransmission—a comparable breakthrough in immunology could open entirely new therapeutic avenues.
View original technical description
1. IMPORTANCE: Macrophages instruct the functions of other innate cells to coordinate the type and timing of inflammatory responses. We recently identified CALHM6 as an interferon- and TLR-inducible membrane protein on macrophages, important for macrophage-mediated instruction of early innate responses to infections. Proteins of the CALHM family have only been characterised in the neuronal system, where they act as ATP-permeable ion channels. They promote cell-cell crosstalk at neuronal synapses by releasing a small molecule ATP, which acts as a neurotransmitter. CALHM6 is the only CALHM family member highly expressed in immune cells. It has been linked to the induction of natural killer (NK) cell anti-tumour activity. The mechanism of action and broader functions of CALHM6 in the immune system were unclear. We generated CALHM6-deficient mice and found that CALHM6 controlled infection-induced innate cell cross-talk at the immunological synapse, and was required for the early control of Listeria monocytogenes infection in vivo. CALHM6 expression was highest on activated macrophages in the presence of pathogen-derived signals or interferons. CALHM6 expression was transient and transcriptionally terminated by anti-inflammatory cytokines. Mechanistically, our patch clamp studies in Xenopus oocytes revealed that CALHM6 can form a membrane ion channel, in which a conserved acidic residue E119 controlled channel opening. When overexpressed in Xenopus oocytes, CALHM6 was constitutively open and toxic to cells. In mammalian cells, however, CALHM6 localized to the inside of the cell and, hence, no channel activity or toxicity was detected or reported. We found that only upon macrophage activation does CALHM6 rapidly re-localise from the intracellular compartment to the immune synapse, where it controls the early kinetics of natural killer cell activation in vivo and innate defences from infection. How is CALHM6 recruited to the synapse? Does CALHM6 form a synaptic ATP channel in activated macrophages? What functional programmes does CALHM6 regulate in NK cells? These key questions form the focus of this proposal. 2. HYPOTHESIS AND PROJECT AIMS: Hypothesis: In activated macrophages, CALHM6 translocates to the immune synapse to form a metabolite-permeable membrane channel important for natural killer cell activation. We will use bone marrow-derived macrophages from our WT and Calhm6-/- mice reconstituted WT or E119R channel-dead mutant control to address the following Aims: Objective 1: Generate a time-resolved map of CALHM6 trafficking in resting and activated macrophages as they form immune synapses with natural killer cells. Objective 2: Identify CALHM6 interactome in the resting state and upon synapse formation, to understand the molecular basis for intracellular retention and activation-induced relocalisation. Objective 3: Test whether membrane-targeted CALHM6 can form a metabolite-permeable synaptic channel and define CALHM6-dependent functional programmes.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know